Vitamins a and B3: a new shield against skin cancer for transplant patients?
NCT ID NCT05702398
Summary
This early-stage study is testing whether daily vitamin A and vitamin B3 (nicotinamide) supplements are safe and can change blood nutrient levels in kidney transplant patients who have a high risk of skin cancer. The goal is to gather initial data to see if these vitamins could be used in future studies aimed at preventing skin cancer in this vulnerable group. The study will enroll 30 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rhode Island Hospital
RECRUITINGProvidence, Rhode Island, 02912, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.